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Comparison of the Effect of 
Oestrogen Plus Foeniculum vulgare 
Seed and Oestrogen alone on 
Increase in Endometrial Thickness in 
Infertile Women
INTRODUCTION 
Infertility is one of the common healthcare issues that many 
couples worldwide are facing [1]. In Iran, infertility is a common 
issue associated with several outcomes such as aggression, social 
stigma, exclusion, and emotional-psychological problems that 
lead ultimately to adverse effects on quality of life [2,3]. In addition, 
infertility brings stupendous health care costs for women and their 
families and leads to economic instability in the health care system 
[4]. ET is one of the factors that plays an important role in infertility. 
Women with 6 mm<ET≤10 mm endometrial thickness have greater 
chance of pregnancy [5]. 
To achieve successful implementation in Assisted Reproductive 
Technologies (ARTs), ET should be taken into account to increase 
fertility likelihood [6,7]. This issue is not considered to deserve much 
investigation by fertility specialists in treating infertility [8]. Oestrogen 
therapy is an effective and side effect free approach to treat 
inadequate ET in folliculogenesis and ovulation [9], because it has 
been recommended to increase ET using oestrogen supplements 
in women without adequate ET. Oestrogen supplements have also 
been investigated for their effects in preventing the complications of 
ET-reducing infertility drugs such as clomiphene citrate [9,10]. 
In addition to synthetic drugs, plants are used to treat problems 
due to infertility including fennel (Foeniculum vulgare Mill). F. vulgare 
is from family Apiaceae (Umbelliferae) that occurs perennially in 
temperate regions and Mediterranean Basin. Because F. vulgare 
seeds have pleasant smell and taste, they are abundantly used 
in food industries. This seed is used as stimulant, carminative, 
anti cancer, and anti-inflammatory in different organs of the body 
[11,12]. F. vulgare aromatic seeds have also certain properties such 
as dysmenorrhea reducing, menstruation symptoms reducing, 
delivery facilitating, milk secretion increasing, libido increasing, and 
premenstrual syndrome symptoms reducing properties. In addition, 
they are used to treat different gynaecological disorders because 
they have oestrogenic properties [13-15]. 
Given that F. vulgare is a phytoestrogen, can be a potentially suitable 
alternative to oestrogen because of being economical and causing 
fewer side effects, and has many uses in Iranian traditional medicine; 
hence, we conducted this study to comparatively investigate the 
effects of oestrogen plus F. vulgare and oestrogen alone on ET in 
infertile women.
MATERIALS AND METHODS 
The study population of this randomised clinical trial that was 
conducted in April 2014 to December 2014 consisted of 98 
infertile women with indication of Frozen Embryo Transfer (FET) 
protocol. Randomisation was done with 92 labeled cards, selected 
by the patients randomly. Participants were enrolled according to 
convenience sampling if they met the inclusion criteria including 
being diagnosed with infertility irrespective of having previous fertility 
and FET indication. The exclusion criteria were patients suffering from 
chronic systemic diseases, incidence of severe side effects, failing to 
follow up the patient carefully, and not volunteering to participate in 
the study. The patients provided informed consent to participate in 
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ABSTRACT
Introduction: Foeniculum vulgare seed is used to treat infertility 
because of phytoestrogenic properties. 
Aim: The present study was conducted to compare the effects 
of F. vulgare plus oestrogen and oestrogen alone on Endometrial 
Thickness (ET) in infertile women.
Materials and Methods: In this study, 92 people with infertility 
were enrolled by convenience sampling and randomly divided 
into treatment case (45 women) and control (47 women) groups. 
Both groups were administered with oestradiol valerate 2 mg 
tablet three times a day since the third day of the menstrual 
cycle. Treatment group was also administered with F. vulgare 
tea on a daily basis. Then, ultrasound was conducted once 
every three days to determine ET. Other data such as serum 
β-hCG level and increase in oestrogen dose were recorded in 
a checklist. The data were analysed by independent t-test and 
Chi-square in SPSS version 17.0. 
Results: There were no significant differences in mean age, 
BMI, number of years of infertility, number of children, cause 
of infertility, positive β-hCG, failure to achieve adequate 
endometrial thickness, and increase in oestradiol dose between 
the treatment and control groups (p>0.05). The mean number 
of days to achieve ET of at least 8 mm was 13.1±3.2 in the 
treatment group and 14.2±3.5 in the control group with no 
significant difference (p>0.05). 
Conclusion: F. vulgare seed tea was not significantly effective 
in increasing the ET as compared to oestradiol valerate 6 mg 
alone.
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the study after the study protocol was registered in Iranian Registry 
of Clinical Trials (registration code: IRCT2014120210617N2) and 
ethical permission was obtained from Hamedan University of 
Medical Sciences with approval number 16.935.699. Then, they 
were randomly assigned to two groups, treatment and control, 
according to random number table [Table/Fig-1].
In addition, no significant difference in the number of oestradiol 
doses was seen between the two groups (p=0.648) [Table/Fig-4]. 
DISCUSSION 
The present study was conducted to investigate the effect of 
F. vulgare seed on infertile women's ET to achieve a thickness 
adequate for fertility. To the best of our knowledge, no study has 
yet been done to investigate this issue. This study demonstrated 
that taking 200 mg/dL of F. vulgare seed tea per day decreased the 
mean number of days required to achieve at least 8 mm ET (though 
statistically insignificant). Sadr Fozlaee S et al., study indicated 
that treatment with F. vulgare helped to regulate the secretion of 
oestrogen and progesterone and therefore led to increase in ET 
and decrease in epithelium [19]. A study on menopausal women 
indicated that phytoestrogens prevented endometrial tissue atrophy 
and could be used as safe herbal compounds [20]. Studies shows 
that medicinal plant like Cimicifuga racemosa [21] and Aspalathus 
linearis [22] and plant derivatives such as klimadynon [23] and 
icariin [24] can increase endometrial thickness. Also some of plant 
formulations such as Xiaoyao powder have oestrogenic effect and 
can increase cell proliferation in endometrial layer [25].
F. vulgare seed contains certain phytoestrogens such as isoflavones, 
prenylated flavonoids, and coumestans [26]. F. vulgare's oestrogenic 
Oestradiol valerate 
dose
Oestradiol valerate plus 
Foeniculum vulgare
Oestradiol 
valerate
p-value
(Chi-
square)no. (%) no. (%)
6 mg (baseline dose) 19 (42.2) 15 (31.9)
0.648
8 mg 11 (24.5) 11 (23.4)
10 mg 8 (17.8) 10 (21.3)
12 mg 7 (15.5) 11 (23.4)
[Table/Fig-4]: Comparison of the number of patients requiring increased dose of 
oestradiol between two groups. 
variables
Oestradiol valerate plus 
Foeniculum vulgare
Oestradiol 
valerate
p-value
(Chi-
square)no. (%) no. (%)
Cause of infertility
0.765
  Male infertility 27 (60) 31 (66)
  Tubular 5 (11.1) 3 (6.4)
  Ovular 4 (8.9) 5 (10.6)
  Combined 7 (15.6) 6 (12.7)
  Miscellaneous 2 (4.4) 2 (4.2)
Previous surgery 9 (20) 8 (17.0) 0.565
β-hCG Positive 6 (13.3) 5 (10.6) 0.718
Failure to achieve 
ET* of 8 mm
1 (2.2) 2 (4.2) 0.674
[Table/Fig-3]: Comparison of cause of infertility, previous surgery, positive β-hCG, 
and failure to achieve adequate endometrial thickness between two groups. 
* Endometrial thickness.
Both groups were administered with oestradiol valerate 2 mg tablet 
(Aburaihan Pharmaceutical Co., Tehran, Iran) three times a day 
since the third day of the menstrual cycle. Treatment group was 
also administered with F. vulgare tea on a daily basis. 
To prepare the tea, 50 mL of boiling water was added to 10 gm of 
F. vulgare seed and the resulting solution brewed for 20 minutes 
[16]. After starting treatment with oestrogen, the patients underwent 
vaginal ultrasound (Samsung Medison, SonoAce R3, Seoul, South 
Korea, 6-MHz vaginal transducer) and ET of approximately 1 cm 
below the the fundus from the external margin of the endometrium 
contact surface with the myometrium to endometrial stripe outer 
margin [17] was measured by an experienced radiologist. If 
the endometria of the patients did not respond to the treatment 
appropriately based on the findings of the two ultrasounds, the 
dose of administered oestrogen increased to four, five, or six 2 mg 
tablets a day, but the amount of the administered F. vulgare tea did 
not change. When ET reached 8 mm or over, FET was conducted 
by the same protocol and instruments for the patients of the two 
groups and the parents were followed up for two weeks after the 
FET to investigate β-hCG result. Serum β-hCG level of over 50 
milli-international unit/mL was considered to represent chemical 
pregnancy [18]. 
The data on each patient were recorded in a separate checklist 
including demographic characteristics, the day when ET reached 8 
mm, failure to achieve ET of 8 mm, and β-hCG results two weeks 
after the FET. The data were analysed by descriptive statistics, 
independent t-test, and Chi-square in SPSS version 17.0. 
RESULTS
There was no significant difference in age, body mass index, the 
number of years of infertility, the number of children, and the mean 
number of days to achieve adequate (8 mm) ET between the two 
groups [Table/Fig-2]. 
Chi-square test indicated no significant difference in cause 
of infertility, previous surgery (any previous invasive vaginal or 
abdominal surgery on upper genital tract), positive β-hCG, and 
failure to achieve adequate ET (p>0.05) [Table/Fig-3]. 
[Table/Fig-1]: Flowchart of allocation of participants to treatment group and 
control group.        
variables
Oestradiol valerate 
plus Foeniculum 
vulgare (n=45) 
Mean±Standard 
deviation
Oestradiol valerate 
(n=47) Mean±Standard 
deviation
p-
value
Age (year) 30.7±5.4 30.1±6.3 0.716
BMI (kg/m2) 25.95±3.25 26.9±2.6 0.627
Number of years of 
infertility
6.00±2.80 6.4±1.1 0.649
Number of children 0.13±0.50 0.06±0.25 0.522
Number of days to 
achieve adequate ET 
13.10±3.20 14.2±3.5 0.591
[Table/Fig-2]: Comparison of demographic features between the two groups. 
BMI: Body mass index 
ET: Endometrial thickness
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activity is attributed to a compound named anatole. Trans-anatole 
comprises over 80% of F. vulgare compounds [27-29]. Oestrogenic 
compounds (like phytoestrogens) increases endometrial thickness 
by affecting glands and endometrial cells and increasing the blood 
flow of the functional layer [30,31]. A small amount of alcoholic F. 
vulgare extract causes increase in alkaline phosphatase activity and 
therefore cell growth and proliferation [31,32]. 
Inconsistency in the findings of the current study and other 
studies can be explained by the fact that phytoestrogens (such 
as isoflavones) largely bind to beta-type oestrogen receptor [33] 
but alpha-type oestrogen receptor represents the main oestrogen 
receptor in the endometrium [34,35]. Therefore, low doses of 
phytoestrogens are likely to be influenced by the method of brewing 
F. vulgare (F. vulgare tea), and the bioavailability of F. vulgare active 
compounds (anatole and oestragole) may be affected by the route 
of administration (oral or local) or the extract type. Consistently, a 
number of studies have reported that phytoestrogens have no effect 
on ET in menopausal women [35-37]. 
Although, more patients in the treatment group needed increase 
in dose compared to the control group, the difference was not 
statistically significant. Besides that, treatment with F. vulgare 
caused increase in the mean rate of chemical pregnancy yet 
insignificantly. F. vulgare antioxidant properties have been reported 
to cause increase in fertility in mice through destroying cells and 
facilitating cell growth and folliculogenesis [38]. 
A study demonstrated that low ET caused difficulty for endometrial 
glandular growth, disrupted angiogenesis process, and 
subsequently decreased secretion of vascular endothelial growth 
factor. More clearly, inadequate endometrial bed leads to weak 
implantation and vascularisation and therefore early abortion [39]. 
However, it is not sufficient to determine and exclusively consider 
ET and prescribe human chorionic gonadotropin to treat infertility, 
and other factors such as appropriate endometrial tissue (triple-
line) and embryo quality should be taken into account [7] as well.
LIMITATION
Not determining the active dose of F. vulgare and not isolating 
phytoestrogenic compounds of this plant are some limitations of 
the current study. It is recommended to conduct studies with larger 
sample size and longer follow-up as well as considering molecular, 
genetic, and histopathological characteristics. Although, there were 
no clinical side effect in treatment group, but it is recommended that 
this can be considered in future studies. 
CONCLUSION
F. vulgare seed tea caused no significant effect on ET compared to 
oestradiol valerate 6 mg tablet alone. However, further studies are 
needed to investigate this issue.
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